Literature DB >> 28713018

Effect of increased surface hydrophobicity via drug conjugation on the clearance of inhaled PEGylated polylysine dendrimers.

Shadabul Haque1, Victoria M McLeod2, Seth Jones3, Sandy Fung4, Michael Whittaker1, Michelle McIntosh2, Colin Pouton2, David J Owen5, Christopher J H Porter6, Lisa M Kaminskas7.   

Abstract

PEGylated polylysine dendrimers are attractive and well tolerated inhalable drug delivery platforms that have the potential to control the release, absorption kinetics and lung retention time of conjugated drugs. The clinical application of these systems though, would likely require partial substitution of surface PEG groups with drug molecules that are anticipated to alter their lung clearance kinetics and clearance pathways. In the current study, we therefore evaluated the impact of increased surface hydrophobicity via substitution of 50% surface PEG groups with a model hydrophobic drug (α-carboxyl OtButylated methotrexate) on the lung clearance of a Generation 5 PEGylated polylysine dendrimer in rats. PEG substitution with OtBu-methotrexate accelerated lung clearance of the dendrimer by increasing polylysine scaffold catabolism, improving systemic absorption of the intact dendrimer and low molecular weight products of scaffold catabolism, and enhancing mucociliary clearance. These results suggest that the conjugation of hydrophobic drug on the surface of a PEGylated dendrimer is likely to accelerate lung clearance when compared to a fully PEGylated dendrimer. Crown
Copyright © 2017. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Clearance; Dendrimer; Drug delivery; Inhalation; Pulmonary

Mesh:

Substances:

Year:  2017        PMID: 28713018     DOI: 10.1016/j.ejpb.2017.07.005

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  5 in total

Review 1.  Pharmacokinetics of inhaled nanotherapeutics for pulmonary delivery.

Authors:  Andrew M Shen; Tamara Minko
Journal:  J Control Release       Date:  2020-07-16       Impact factor: 9.776

Review 2.  Biomedical nanomaterials for immunological applications: ongoing research and clinical trials.

Authors:  Vincent Lenders; Xanthippi Koutsoumpou; Ara Sargsian; Bella B Manshian
Journal:  Nanoscale Adv       Date:  2020-08-24

Review 3.  Overcoming Hurdles in Nanoparticle Clinical Translation: The Influence of Experimental Design and Surface Modification.

Authors:  Jacob W Shreffler; Jessica E Pullan; Kaitlin M Dailey; Sanku Mallik; Amanda E Brooks
Journal:  Int J Mol Sci       Date:  2019-11-30       Impact factor: 5.923

Review 4.  Recent Advances in Epsilon-Poly-L-Lysine and L-Lysine-Based Dendrimer Synthesis, Modification, and Biomedical Applications.

Authors:  Sijin Chen; Shuting Huang; Yan Li; Chuncai Zhou
Journal:  Front Chem       Date:  2021-03-30       Impact factor: 5.221

Review 5.  Highly Branched Polymers Based on Poly(amino acid)s for Biomedical Application.

Authors:  Marisa Thompson; Carmen Scholz
Journal:  Nanomaterials (Basel)       Date:  2021-04-26       Impact factor: 5.076

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.